These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17630574)

  • 1. Rhinocerebral zygomycosis in an HIV-infected man during therapy with an investigational CCR5 inhibitor.
    Merchant S; Reichman R; Koval CE
    AIDS; 2007 Jul; 21(12):1666-9. PubMed ID: 17630574
    [No Abstract]   [Full Text] [Related]  

  • 2. More problems with entry inhibitor.
    AIDS Patient Care STDS; 2006 May; 20(5):380. PubMed ID: 16758552
    [No Abstract]   [Full Text] [Related]  

  • 3. CCR5 antagonists in the treatment of HIV-infected persons: is their cancer risk increased, decreased, or unchanged.
    McNiff T; Dezube BJ
    AIDS Read; 2009; 19(6):218-22, 224. PubMed ID: 19642239
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-HIV agents. Vicriviroc: is the risk of cancer increased?
    TreatmentUpdate; 2006; 18(4):5-6. PubMed ID: 17209230
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term safety study of vicriviroc presented.
    Proj Inf Perspect; 2008 Dec; (47):13. PubMed ID: 19227564
    [No Abstract]   [Full Text] [Related]  

  • 6. Vicriviroc, a CCR5 receptor antagonist for the potential treatment of HIV infection.
    Klibanov OM
    Curr Opin Investig Drugs; 2009 Aug; 10(8):845-59. PubMed ID: 19649929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term data on vicriviroc released.
    AIDS Patient Care STDS; 2009 Nov; 23(11):989. PubMed ID: 19938348
    [No Abstract]   [Full Text] [Related]  

  • 8. Disappointing results for vicriviroc.
    AIDS Patient Care STDS; 2010 Mar; 24(3):197-8. PubMed ID: 20238442
    [No Abstract]   [Full Text] [Related]  

  • 9. New CCR5 antagonist enters phase II trials. Drug would be first-line therapy.
    AIDS Alert; 2008 Aug; 23(8):89-90. PubMed ID: 18724488
    [No Abstract]   [Full Text] [Related]  

  • 10. Better results from vicriviroc with new Trofile test.
    Proj Inf Perspect; 2008 Dec; (47):12. PubMed ID: 19227563
    [No Abstract]   [Full Text] [Related]  

  • 11. CCR5 entry inhibitor problems: no clear answers yet.
    James JS
    AIDS Treat News; 2005; (416):4-5. PubMed ID: 16388544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the chemokine receptor CCR5: good for HIV, what about other viruses?
    Keynan Y; Juno J; Kasper K; Rubinstein E; Fowke KR
    J Infect Dis; 2011 Jan; 203(2):292; author reply 293. PubMed ID: 21288830
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-HIV agents. Receptor blocker (SCH 532706) enters clinical trials.
    TreatmentUpdate; 2008 Mar; 20(2):8-9. PubMed ID: 18663778
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergencies in HIV medicine.
    Rewari BB; Tanwar S
    J Indian Med Assoc; 2009 May; 107(5):317-22. PubMed ID: 19886387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety concerns about CCR5 as an antiviral target.
    Telenti A
    Curr Opin HIV AIDS; 2009 Mar; 4(2):131-5. PubMed ID: 19339952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CCR5 antagonists: a new class of antiretrovirals].
    Peytavin G; Calvez V; Katlama C
    Therapie; 2009; 64(1):9-16. PubMed ID: 19463248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CCR5 inhibitors. A new point of attack for HIV infection].
    Heinzl S
    Med Monatsschr Pharm; 2007 Dec; 30(12):434-8; quiz 439-40. PubMed ID: 18196845
    [No Abstract]   [Full Text] [Related]  

  • 18. [HIV infection 2007].
    Potthoff A; Brockmeyer N;
    Med Klin (Munich); 2007 Jul; 102(7):531-9. PubMed ID: 17634871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV agents. Vicriviroc.
    TreatmentUpdate; 2008 Mar; 20(2):9-10. PubMed ID: 18661648
    [No Abstract]   [Full Text] [Related]  

  • 20. Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors.
    Arastéh K; Stocker H
    Eur J Med Res; 2007 Oct; 12(9):397-402. PubMed ID: 17933720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.